Drug developers place their bets on the ROR-1 antigen in the battle against solid tumors.

Sending out instrumentation to trade shows or customer locations for demonstration purposes is expensive and not risk free. Enter 3D virtual worlds.

We interview Freya Biosciences' Colleen Acosta about the need for more therapies to address healthcare issues specific to women.

Why the FDA must delete its statement that people are not horses (or cows), referring to ivermectin use

In this video interview, Courtney Silverthorn explains the inspiration behind a free regulatory playbook for gene therapy manufacturers.

Production records written using erasable markers, use of expired raw materials, and more.

Day 3 closes out with sessions on drug delivery devices

Looking for a guide to day 2 of the show? We’ve got you covered.

Lonza’s Enprotect Capsule is the recipient of The Medicine Maker 2023 Innovation Awards.

Interphex kicks off today in New York. Here’s what to look out for on day 1.